Evidence map›Paper›PMID 30655229›Full record

ArticleThe Lancet. Public health2019

Premature mortality from all causes and drug poisonings in the USA according to socioeconomic status and rurality: an analysis of death certificate data by county from 2000-15.

Meredith S Shiels, Amy Berrington de González, Ana F Best, Yingxi Chen, Pavel Chernyavskiy, Patricia Hartge, Sahar Q Khan, Eliseo J Pérez-Stable, Erik J Rodriquez, Susan Spillane and 3 more

Open access · goldAbstract read
In one paragraph

Article in The Lancet. Public health, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
7.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 63 citations in OpenAlex.

  1. Article
  2. Observational
  3. Severe housing cost burden and premature cardiovascular mortality.American journal of preventive cardiology · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 1 country.

Meredith S ShielsDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA. Electronic address: shielsms@mail.nih.gov.
Amy Berrington de GonzálezDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
Ana F BestDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
Yingxi ChenDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
Pavel ChernyavskiyDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA; University of Wyoming, Department of Mathematics and Statistics, Laramie, WY, USA.
Patricia HartgeDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
Sahar Q KhanDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
Eliseo J Pérez-StableOffice of the Director, National Institute on Minority Health and Health Disparities, Bethesda, MD, USA.
Erik J RodriquezDivision of Intramural Research, National Heart, Lung, and Blood Institute, Bethesda, MD, USA.
Susan SpillaneDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
David A ThomasDivision of Epidemiology, Services and Prevention Research, National Institute on Drug Abuse, Bethesda, MD, USA.
Diana WithrowDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
Neal D FreedmanDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
Division of Cancer Epidemiology and GeneticsNational Cancer Institute · USNational Heart Lung and Blood Institute · USNational Institute on Drug Abuse · USOffice of the Director · USUniversity of Wyoming · US

Funding

Infections, immunity, and inflammation in cancerZIACP010150 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI ENGELS, ERIC A · 2009 to 2025
$24.0M
Intramural NIH HHS Z99 CA999999Intramural NIH HHS Z99 HL999999Intramural NIH HHS Z99 MD999999
6 · The paper itself

Abstract

backgroundIncreasing premature mortality among some groups of Americans has been largely driven by increases in drug poisoning deaths. However, to our knowledge, a formal descriptive study by race and ethnicity, socioeconomic status, rurality, and geography has not been done. In this study, we examined US trends in premature all-cause and drug poisoning mortality between 2000 and 2015 at the county level among white, black, and Latino people.

methodsWe used US mortality data for the period Jan 1, 2000, to Dec 31, 2015, including underlying cause of death and demographic data, collected from death certificates by the Centers for Disease Control and Prevention National Center for Health Statistics, and ascertained county attributes from the 2011-15 Census American Community Survey. We categorised counties into quintiles on the basis of the percentage of people unemployed, the percentage of people with a bachelor's degree, median income, and rurality. We estimated premature (ie, deaths in those aged 25-64 years) age-standardised mortality for all causes (by race and ethnicity) and drug poisoning, by county, for the periods of 2000-03 and 2012-15. We estimated annual percentage changes in mortality (2000-15) by county-level characteristics.

findingsPremature mortality declined from 2000-03 to 2012-15 among black and Latino people, but increased among white people in many US counties. Drug poisoning mortality increased in counties throughout the country. Significant increases between 2000 and 2015 occurred across low and high socioeconomic status and urban and rural counties among white people aged 25-64 years (annual percentage change range 4·56% per year [95% CI 3·56-5·57] to 11·51% per year [9·41-13·65]), black people aged 50-64 years (2·27% per year [0·42-4·16] to 9·46% per year [7·02-11·96]), Latino women aged 25-49 years (2·43% per year [1·18-3·71] to 5·01% per year [3·80-6·23]), and Latino men aged 50-64 years (2·42% per year [0·53-4·34] to 5·96% per year [3·86-8·11]). Although drug poisoning mortality increased rapidly in counties with the lowest socioeconomic status and in rural counties, most deaths during 2012-15 occurred in the largest metropolitan counties (121 395 [76%] in metropolitan counties with ≥250 000 people vs 2175 [1%] in the most rural counties), reflecting population size.

interpretationPremature mortality has declined among black and Latino people in the USA, and increased among white people, particularly in less affluent and rural counties. Increasing drug poisoning mortality was not limited to poor white people in rural areas. Rapid increases have occurred in communities throughout the USA regardless of race and ethnicity, socioeconomic status, or rurality. Widespread public health interventions are needed to addess this public health emergency.

fundingNational Institutes of Health.

Indexed as

Health Status DisparitiesAdultCause of DeathDeath CertificatesDrug OverdoseFemaleHumansMaleMiddle AgedMortality, PrematurePoisoningRural PopulationSocial ClassUnited States

Identifiers

PMID30655229
PMCPMC6392082
OpenAlexW2908850036

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.